We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Device Detects Human Errors in Preparing Liquid Medications

By HospiMedica International staff writers
Posted on 02 Feb 2010
Image: The ValiMed Medication Validation System (photo courtesy CDEX).
Image: The ValiMed Medication Validation System (photo courtesy CDEX).
A tabletop analysis device provides a technological safety net that grants protection from medication errors for patients, pharmacists, and hospitals.

The ValiMed Medication Validation System (MVS), engineered to eliminate mistakes made while mixing compounds at a hospital, uses a technique called enhanced photoemission spectroscopy to determine if the compounds mixed are the correct ones.

The easy to operate, compact, and self contained system only needs a 0.15 ml sample to perform the test, and an average test takes less than 30 seconds to complete. In addition to validating high-risk medications before leaving the pharmacy, ValiMed also monitors and discourages the diversion of controlled narcotic substances by validating the returned (unused) narcotics from patient treatment areas and surgery suites. The system also provides the user with the ability to print both an immediate results label (for log books or product packaging) as well as final reports detailing validation results across many different filters (such as date, user, technician, practitioner, and medication).

Additional features include the ability to monitor the technician's accuracy to improve compounding performance, counterfeit medication monitoring, and regulatory compliance. The system contains a signature library of nearly 200 liquid high-risk medications, allowing each system to be customized to the customer's needs. These proven signatures are derived from tested samples to achieve statistical significance through mathematical processing, dilution and concentration studies, and medical reviews. The development of new medication signatures are undertaken based on client needs. The ValiMed MVS is a product of CDEX (Tucson, AZ, USA).

"ValiMed is the only technology available today that prevents harm to patients from human errors in the compounding of high-risk medications,” said Chris Jerry, President of the Emily Jerry Foundation.” I believe that those hospitals which have adopted the ValiMed MVS as part of their medication safety programs have set the standard of care, and all hospitals should follow suit.”

The Emily Jerry Foundation (Mentor, OH, USA), a nonprofit foundation working to prevent medical errors, was founded in memory of Chris Jerry's two-year-old daughter Emily, who died from an overdose of sodium chloride. The foundation was established in May 2009 shortly after Ohio (USA) legislators passed Emily's Law, which created licensing and minimum education requirements for pharmacy technicians. The foundation's mission is to protect children from medical errors, and it is actively working to save lives as well as make medical facilities safer by partnering with key organizations and businesses to promote life-saving technologies.

Related Links:

CDEX
The Emily Jerry Foundation


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Pediatric Mask
Respire SOFT
Hybrid Arch Device
Neo EDE

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more